C-di-AMP synergizes with radiotherapy-induced tumor antigen release, particularly double-stranded DNA, to enhance dendritic cell maturation and antigen presentation, promoting IFN production and activating CD8+ cytotoxic T cells in a cGAS- and STING-dependent manner [30]. This evidence concerns the gene CD8A and neoplasm.